-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
| The U. The National Institutes of Health (NIH) has previously allocated approximately US$190 million to support the research of the Somatic Cell Genome Editing (SCGE) Consortium. Genetic factors are the "culprits" that cause most human diseases, including genetic diseases, infectious diseases and many malignant diseases. At present, gene therapy is achieving greater and greater success, but scientists believe that the field of somatic gene editing requires new editing, delivery and biological systems to better measure the safety and effectiveness of various strategies. This time, a joint research team including the University of Wisconsin and the University of Massachusetts published opinions and introduced and discussed related plans, including: developing new technologies to induce and evaluate genome editing, and determine the downstream functional consequences of genome editing in human cells; At the same time, it adheres to a rigorous and innovative method to verify through third-party testing of small and large animals; and then visualize the "assembled" SCGE "toolkit" and the knowledge generated by the application to accelerate researchers' understanding of various diseases Clinical development of new therapies. The article stated that this project will strictly focus on somatic cell editing, focusing on two aspects: one is from the DNA in the nucleus to the nucleic acid elsewhere in the cell; the other is not changing the DNA or RNA sequence to produce chromatin structure The targeted change is the targeted epigenome editing. The plan will also establish a common indicator or standard, and then compare multiple technologies.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
Welcome to ECHEMI 
|
